3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Gastrointestinal Stromal Tumors
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Neoplasm Metastasis
3
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Bile Duct Neoplasms
2
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Physician Education
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan Syndrome 6
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Insulinoma
1
Interventions
Cisplatin
27
Cetuximab
17
Radiotherapy
14
Carboplatin
14
pembrolizumab
11
Paclitaxel
11
Drug Therapy
8
Radiotherapy, Intensity-Modulated
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
Radiation
6
Docetaxel
5
130-nm albumin-bound paclitaxel
5
Panitumumab
4
Chemoradiotherapy
3
Capecitabine
3
Bevacizumab
3
Albumin-Bound Paclitaxel
3
Afatinib
3
selinexor
2
figitumumab
2
Restraint, Physical
2
Radiosurgery
2
Methotrexate
2
Lapatinib
2
Everolimus
2
Esophagectomy
2
Cyclophosphamide
2
zalutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Squamous Cell
×
regorafenib
×
Clear all
No trials found.